Recruiting Clinical Trials

Displaying 81 - 90 of 213 result(s)
Study Title Condition Phase Location
Phase Ib Study of Gevokizumab in Combination With Standard of Care Anti-cancer Therapies in Patients With Metastatic Colorectal Cancer, Gastroesophageal Cancer and Renal Cell Carcinoma Colorectal Cancer, Gastroesophageal Cancer, Renal Cell Carcinoma Phase 1
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Phase III Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET Gastro-enteropancreatic Neuroendocrine Tumor Phase 3
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    France
  • Country: 
EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum ( ... PIK3CA-related Overgrowth Spectrum (PROS) Phase 2
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    France
  • Country: 
An Open-label, Multi-center, Phase IV Roll-over Study in Patients With ALK Positive Malignancies Who Have Completed a Novartis-sponsored Ceritinib (LDK378) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Ceritinib ALK Positive Malignancies Phase 4
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    Brazil
  • Country: 
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositi ... Triple Negative Breast Neoplasms Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Res ... Non-Small Cell Lung Cancer Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Austria
  • Country: 
Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma Phase 4
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Austria
  • Country: 
A Phase II Randomized Double-blind, Placebo-controlled Study of Alpelisib in Combination With Fulvestrant for Chinese Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, PIK3CA Mutant Advanced Breast Cancer Which Progressed on ... Breast Neoplasms Phase 2
  • Country: 
    China
An Open Label, Multicenter Roll-over Extension Program (REP) to Characterize the Long-term Safety and Tolerability of Iptacopan (LNP023) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Completed PNH Phase 2 and Phase3 Studies With ... Paroxysmal Nocturnal Hemoglobinuria Phase 3
  • Country: 
    Italy
  • Country: 
    Korea, Republic of
  • Country: 
    Taiwan
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous ... Familial Hypercholesterolemia - Homozygous Phase 3
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    France
  • Country: